qiagen enjoy posit moat trend genom
appear fairli valu
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim sep
price data sep
rate updat sep
currenc amount express
methodolog valu compani
take fresh look genom firm
maintain moat rate -- narrow
none -- increas moat
trend posit stabl on-going innov
help compani expand new market opportun
keep long-term growth higher pace
firm life science/diagnost coverag also
valuat perspect recent price drop push
share closer fair valu opinion
although significantli differ view qualiti
underli busi reflect moat
rate see posit moat trend compani
relat strong innov pipelin look like
open new market opportun organ
specif remain focus reduc cost
genom sequenc make technolog
access broader rang applic includ
clinic diagnost go forward addit grow
sequencing-rel busi also pursu new
platform expans diagnost platform
test pipelin long-term growth
margin trajectori firm look strong new product
launch also contribut expand intang
asset switch cost compani
howev near-term outlook
remain long-term prospect pullback
share recent month stock appear
reason valu opinion share recent
trade slight premium new fair valu
estim per share share trade roughli
line fair valu estim per share
experienc weaker growth due
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
provid tool servic analyz genet materi life
scienc clinic lab applic compani gener revenu
sequenc tool dedic consum sale
human larg organ lower throughput tool enabl
applic requir smaller data output viral cancer
tumor screen also sell microarray sale enabl
lower-cost focus genet screen primarili consum
agricultur applic servic account sale includ
basic mainten servic clinic lab applic non-invasive
prenat oncolog rare-diseas screen whole genom
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
includ breakdown chines
joint ventur provid sequenc servic full
innov pipelin though expect top-
bottom-lin growth acceler beyond sale
growth earn per share growth compound
annual basi expect appear
roughli line manag expect
constant-curr revenu growth least
earn per share growth period share
trade around time expect earn
time expect earn view share
varieti challeng expect growth acceler
beyond pressur subsid
support current fair valu estim first
microarray busi declin relat direct-to-
consum product face tough compar
sever strong year particularli market
servic like ancestri servic like
may need adjust strategi includ health-
relat offer could requir complex
sequenc expand geograph could
eventu benefit also compani see
weaker-than-anticip use consum non-
high-throughput machin may repres
anomali accord manag keep close
eye trend sinc competit forc may work
well
final sever popul genom project would
perform high-throughput instrument
ramp quickli expect view dynam
mere delay growth area rather
perman event includ weak near-term
trend expect mid-single-digit sale earn
per share growth expect
grow depress rate long given larg
opportun ahead compani last four
year explicit forecast period expect
return midteen sale high teen earn per share
expect earn time expect earn
see stock fairli valu howev growth look
like remain weak beyond would
surpris see pullback stock could
provid attract entri point
similarli long-term outlook stronger
near-term prospect specif expect mid-
single-digit growth top bottom line
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
